Nomura analyst Christopher Marai maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) on May 22 and set
Category: Healthcare
Biohaven Pharmaceutical Holding Co (BHVN) Receives a Buy from Canaccord Genuity
In a report issued on May 22, Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Biohaven Pharmaceutical Holding
Seattle Genetics (SGEN) Receives a Buy from J.P. Morgan
In a report issued on May 19, Cory Kasimov from J.P. Morgan maintained a Buy rating on Seattle Genetics (SGEN
Genocea Biosciences (GNCA) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Genocea Biosciences (GNCA – Research Report) on May 19 and
H.C. Wainwright Thinks Xenetic Biosciences’ Stock is Going to Recover
In a report issued on May 19, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Xenetic Biosciences (XBIO
Analysts Are Bullish on These Healthcare Stocks: Kadmon Holdings (KDMN), BioMarin Pharmaceutical (BMRN)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kadmon Holdings
Wedbush Believes Kala Pharmaceuticals (NASDAQ: KALA) Won’t Stop Here
In a report issued on May 22, Liana Moussatos from Wedbush maintained a Buy rating on Kala Pharmaceuticals (KALA –